GlassScriptPhysician profile
Harry Neuwirth
NPI 1326067919
$5,660.44
in general payments reported to CMS, 2019-2025
33 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $265 · 2021: $333 · 2022: $522 · 2023: $1,070 · 2024: $1,867 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,280 · Travel and Lodging: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,280.14 |
| Travel and Lodging | $975.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,292.09 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $1,285.82 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Abbvie INC. | $576.26 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $507.11 | 2023-2024 | Gemtesa, Orgovyx |
| Rochester Medical Corporation | $329.42 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $217.95 | 2019-2025 | Bard Urinary Drainage Bag |
| Astellas Pharma US INC | $161.38 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $124.96 | 2024 | Adstiladrin |
| Janssen Biotech, INC. | $117.20 | 2019-2025 | Erleada |
| Edap Technomed INC | $100.00 | 2023 | |
| Urogen Pharma, INC. | $84.37 | 2021-2022 | |
| Pfizer INC. | $83.59 | 2023-2025 | |
| Telix Pharmaceuticals | $79.21 | 2024-2025 | Illuccix |
| Myriad Genetic Laboratories, INC. | $71.47 | 2022-2024 | Prolaris |
| Blue Earth Diagnostics | $62.39 | 2021-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $60.84 | 2019 | |
| Tolmar, INC. | $58.77 | 2023 | |
| Biotissue Holdings INC. | $46.94 | 2025 | |
| Dendreon Pharmaceuticals LLC | $44.75 | 2019-2020 | |
| Becton, Dickinson and Company | $43.54 | 2024 | Bard Urinary Drainage Bag |
| Angiodynamics, INC. | $33.85 | 2021-2023 | Nanoknife |
| Allergan, INC. | $32.41 | 2021-2022 | |
| Immunitybio, INC. | $31.44 | 2024 | |
| Ambu INC. | $30.24 | 2021 | |
| Smith+Nephew, INC. | $29.49 | 2023 | Stravix |
| Palette Life Sciences, INC. | $28.24 | 2022 | |
| Ethicon US, LLC | $25.80 | 2021 | |
| Accord Healthcare, INC. | $23.81 | 2024 | |
| Teleflex LLC | $21.41 | 2022 | |
| Abbott Laboratories | $20.68 | 2021 | |
| Sagent Pharmaceuticals | $17.79 | 2022 | |
| Olympus America INC. | $15.30 | 2022 | |
| Travere Therapeutics, INC. | $1.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Neuwirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.